ArticleInternational journal of clinical pharmacy2026
Post-marketing safety surveillance of EGFR-targeted agents and disseminated intravascular coagulation risk: a disproportionality analysis based on the FDA Adverse Event Reporting System.
Hai-Yu Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.